Tate & Lyle PLC unveils its new stevia composition, OPTIMIZER STEVIA® 8.10.
Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and beverages, unveils its new stevia composition, OPTIMIZER STEVIA® 8.10.
London, UK, 9 July 2024 – Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and beverages, unveils its new stevia composition, OPTIMIZER STEVIA® 8.10. This innovative ingredient delivers the highly desired premium taste profile closest to sugar, even at high sugar replacement levels, while offering a more cost-effective solution than other premium sweeteners.
This stevia composition offers a comprehensive set of benefits for both manufacturers and consumers. With OPTIMIZER STEVIA® 8.10, manufacturers gain access to a versatile, great tasting stevia at a lower cost-in-use, offering an improved value compared to other premium stevia sweeteners. This translates to delicious, low-calorie options that meet consumer demand without compromising on taste. The unique composition qualifies for labelling as "stevia extract," (following JECFA* guidance) aligning with consumer preference for a sweetener derived from nature.1**
With versatility across applications, OPTIMIZER STEVIA® 8.10 is ideal for achieving a superior taste profile in high sugar-replacement formulations like nutrition bars and shakes, functional beverages, vitamin gummies, and yoghurt.
Abigail Storms, Senior Vice President Global Platform, Sweeteners & Fibers, Tate & Lyle said
"OPTIMIZER STEVIA® 8.10 is a breakthrough for the industry. We've leveraged our technical expertise to create a sweetener that not only meets the highest standards of taste and quality but also delivers cost savings to our customers. OPTIMIZER STEVIA® 8.10 opens a world of possibilities for food and beverage manufacturers because they no longer have to compromise on taste because of cost. Whether you're looking to improve taste, reduce costs, or enhance the nutritional profile of your products, OPTIMIZER STEVIA® 8.10 delivers on all fronts.”
This development underscores Tate & Lyle's unwavering commitment to scientific innovation. Through proprietary production processes, the company has unlocked the potential of previously underutilised steviol glycosides, naturally occurring components within the stevia leaf. This innovative process developed by Tate & Lyle’s scientists and engineers enables greater use of the stevia leaf extract, promoting more efficient manufacturing processes.
1 Tate & Lyle Proprietary Research, 2024 Global Consumer Ingredient Perception Research – US; Base size n=302
* Joint FAO/WHO Expert Committee on Food Additives
** The applicability of label claims and the regulatory and intellectual property status of Tate & Lyle ingredients varies by jurisdiction
END
For more information contact:
Maxine Boersma
Senior Manager, Global Corporate PR, Tate & Lyle
+44(0)7766361515
--------------------------------------------------------------
About Tate & Lyle:
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.
Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.
We have more than 3,300 employees working in around 58 locations in 39 countries, serving customers across 121 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2024, Tate & Lyle revenue from continuing operations totalled £1.65 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube.